By G HossainPosted on July 8, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Kalohexis is working on peptide therapies, including one for obesity that could offer an alternative approach to the GLP-1s that currently dominate the weight loss space. Obesity newcomer Kalohexis makes confidential IPO bid 3 months after spinoff Post navigation Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoilNovartis cuts New Jersey workforce again, ousting 322 employees
